LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 36.73 | 84.90 | 145 | 3254 | 0.0446 | 0.1071 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 36.73 | 84.90 | 2570 | 3254 | 0.7897 | 0.9122 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 36.73 | 84.90 | 2307 | 3254 | 0.7089 | 0.8734 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 36.73 | 84.90 | 2326 | 3254 | 0.7147 | 0.8763 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 38.43 | 84.90 | 129 | 3459 | 0.0373 | 0.0814 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 38.43 | 84.90 | 2717 | 3459 | 0.7853 | 0.9117 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 38.43 | 84.90 | 2410 | 3459 | 0.6966 | 0.8693 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 38.43 | 84.90 | 2427 | 3459 | 0.7015 | 0.8717 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 40.14 | 84.90 | 183 | 3682 | 0.0497 | 0.1517 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 40.14 | 84.90 | 2861 | 3682 | 0.7770 | 0.9093 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 40.14 | 84.90 | 2541 | 3682 | 0.6901 | 0.8682 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 40.14 | 84.90 | 2555 | 3682 | 0.6939 | 0.8700 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 41.84 | 84.90 | 188 | 4003 | 0.0470 | 0.1537 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 41.84 | 84.90 | 3010 | 4003 | 0.7519 | 0.9000 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 41.84 | 84.90 | 2636 | 4003 | 0.6585 | 0.8552 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 41.84 | 84.90 | 2646 | 4003 | 0.6610 | 0.8565 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 43.55 | 84.90 | 221 | 4287 | 0.0515 | 0.1842 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 43.55 | 84.90 | 3191 | 4287 | 0.7442 | 0.8982 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 43.55 | 84.90 | 2834 | 4287 | 0.6609 | 0.8589 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 43.55 | 84.90 | 2846 | 4287 | 0.6637 | 0.8603 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 45.25 | 84.90 | 281 | 4539 | 0.0619 | 0.2318 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 45.25 | 84.90 | 3356 | 4539 | 0.7392 | 0.8975 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 45.25 | 84.90 | 2952 | 4539 | 0.6502 | 0.8555 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 45.25 | 84.90 | 2958 | 4539 | 0.6516 | 0.8562 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 46.95 | 84.90 | 322 | 4952 | 0.0650 | 0.2551 | MN20160318_Q02 | K14 |